Cargando…

Cancer Medicines: What Is Essential and Affordable in India?

The WHO essential medicines list (EML) guides selection of drugs for national formularies. Here, we evaluate which medicines are considered highest priority by Indian oncologists and the extent to which they are available in routine practice. METHODS: This is a secondary analysis of an electronic su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sengar, Manju, Fundytus, Adam, Hopman, Wilma, Pramesh, C.S., Radhakrishnan, Venkatraman, Ganesan, Prasanth, Mathew, Aju, Lombe, Dorothy, Jalink, Matthew, Gyawali, Bishal, Trapani, Dario, Roitberg, Felipe, De Vries, Elisabeth G.E., Moja, Lorenzo, Ilbawi, André, Sullivan, Richard, Booth, Christopher M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2022
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812506/ https://www.ncbi.nlm.nih.gov/pubmed/35853192 http://dx.doi.org/10.1200/GO.22.00060

Ejemplares similares

Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey
por: Fundytus, Adam, et al.
Publicado: (2021)

Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey
por: Denburg, Avram E., et al.
Publicado: (2022)

Randomised controlled trials evaluating anticancer therapies in haematological cancers: an overview of global research activity
por: Sengar, Manju, et al.
Publicado: (2023)

Randomized Controlled Trials in Lung, Gastrointestinal, and Breast Cancers: An Overview of Global Research Activity
por: Wells, J. Connor, et al.
Publicado: (2022)

Delivery of Global Cancer Care: An International Study of Medical Oncology Workload
por: Fundytus, Adam, et al.
Publicado: (2017)

Cancer care workforce in Africa: perspectives from a global survey
por: Vanderpuye, Verna, et al.
Publicado: (2019)

A National Cancer Grid pooled procurement initiative, India
por: Pramesh, C S, et al.
Publicado: (2023)

Tracking the Workforce 2020-2030: Making the Case for a Cancer Workforce Registry
por: Srivastava, Archita, et al.
Publicado: (2021)

Affordability and Price Increases of New Cancer Drugs in Clinical Guidelines, 2007–2016
por: Hwang, Thomas J, et al.
Publicado: (2018)

Participation of Lower and Upper Middle–Income Countries in Clinical Trials Led by High-Income Countries
por: Rubagumya, Fidel, et al.
Publicado: (2022)

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
por: Sharma, Shubham, et al.
Publicado: (2021)

Building research capacity in India: The Masters in Clinical Research program at the Tata Memorial Centre
por: Gadgil, Durga, et al.
Publicado: (2021)

Text Messaging in Cancer-Supportive Care: A Systematic Review
por: Wijeratne, Don Thiwanka, et al.
Publicado: (2021)

Management of B-cell lineage acute lymphoblastic leukemia: expert opinion from an Indian panel via Delphi consensus method
por: Mathews, Vikram, et al.
Publicado: (2023)

Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments
por: Trapani, Dario, et al.
Publicado: (2022)

Healthcare delivery for non-communicable diseases among breast cancer survivors in Sri Lanka: Is there a missed opportunity?
por: Wijeratne, Don Thiwanka, et al.
Publicado: (2021)

Global access to affordable direct oral anticoagulants
por: Neumann, Ignacio, et al.
Publicado: (2021)

Acute lymphoblastic leukemia: A single center experience with Berlin, Frankfurt, and Munster-95 protocol
por: Radhakrishnan, Venkatraman, et al.
Publicado: (2015)

Colorectal Cancer Treatment Characteristics and Concordance With Guidelines in Sri Lanka: Results From a Hospital-Based Cancer Registry
por: Wijeratne, Don Thiwanka, et al.
Publicado: (2022)

Can Radiotherapy Be Omitted in Children With Hodgkin Lymphoma Who Achieve Metabolic Remission on Interim Positron Emission Tomography? Experience of a Tertiary Care Cancer Referral Center
por: Totadri, Sidharth, et al.
Publicado: (2017)

Training General Practitioners in Oncology: A Needs Assessment Survey From Nepal
por: Gyawali, Bishal, et al.
Publicado: (2022)

Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic
por: Lombe, Dorothy, et al.
Publicado: (2021)

Voriconazole is a safe and effective anti-fungal prophylactic agent during induction therapy of acute myeloid leukemia
por: Shah, Akash, et al.
Publicado: (2016)

Pediatric Hodgkin Lymphoma Treated at Cancer Institute, Chennai, India: Long-Term Outcome
por: Radhakrishnan, Venkatraman, et al.
Publicado: (2016)

Impact of Strategies for Mitigating Delays and Disruptions in Cancer Care Due to COVID-19: Systematic Review
por: Pacheco, Rafael Leite, et al.
Publicado: (2021)

Competency-based education in general surgery: Are Canadian residents ready?
por: Gauvin, Gabrielle, et al.
Publicado: (2021)

Oncology training programmes for general practitioners: a scoping review
por: Gyawali, Bishal, et al.
Publicado: (2021)

Cancer drugs in LMICs: cheap but unaffordable
por: Gyawali, Bishal
Publicado: (2017)

The OlympiAD trial: who won the gold?
por: Gyawali, Bishal
Publicado: (2017)

Low-value practices in oncology contributing to financial toxicity
por: Gyawali, Bishal
Publicado: (2017)

Me, Too
por: Gyawali, Bishal
Publicado: (2016)

Letter to Editor-response: placebo response rates
por: Gyawali, Bishal
Publicado: (2023)

Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology
por: Kasonde, Lombe, et al.
Publicado: (2019)

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review
por: Riera, Rachel, et al.
Publicado: (2021)

Objective response rate of placebo in randomized controlled trials of anticancer medicines
por: Sachdev, Arushi, et al.
Publicado: (2022)

Outcomes in Lung Cancer: 9-Year Experience From a Tertiary Cancer Center in India
por: Murali, Aditya Navile, et al.
Publicado: (2017)

Negative trials in ovarian cancer: is there such a thing as too much optimism?
por: Gyawali, Bishal, et al.
Publicado: (2016)

Adoptive cell therapy and modulation of the tumour microenvironment: new insights from ASCO 2016
por: Khoja, Leila, et al.
Publicado: (2016)

Cancer treatment in the last 6 months of life: when inaction can outperform action
por: Gyawali, Bishal, et al.
Publicado: (2018)

What Global Oncology Needs: Mutual Learning and More Funding
por: Gyawali, Bishal, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8fuagskaptcp2esh59sn8g5b40